Physician profile
Aleksandr Filen
NPI 1508143769
$3,354.87
in general payments reported to CMS, 2019-2025
14 companies · $2,019 in 2025
The $2,019 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.94 · 2022: $900 · 2023: $169 · 2024: $203 · 2025: $2,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068 · Travel and Lodging: $278 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.88 |
| Travel and Lodging | $278.15 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,602.04 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Boston Scientific Corporation | $509.69 | 2024-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Forte Bio-Pharma LLC | $283.01 | 2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.70 | 2024-2025 | Relistor |
| Curonix LLC | $164.45 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $151.86 | 2025 | Belbuca |
| Genentech, INC. | $148.92 | 2023 | Evrysdi |
| Scilex Pharmaceuticals INC. | $94.22 | 2021-2025 | |
| Abbott Laboratories | $39.50 | 2023-2025 | Prodigy, Thoratec Heartmate 3 Lvas Implant Kit |
| Nalu Medical, INC. | $35.08 | 2024 | Nalu Neurostimulation System |
| Axsome Therapeutics, INC. | $31.23 | 2025 | Symbravo |
| Novo Nordisk INC | $22.79 | 2024 | Wegovy, Saxenda |
| Tonix Medicines, INC. | $15.73 | 2025 | Tonmya |
| Foundation Fusion Solutions, LLC | $8.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleksandr Filen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.